Expression of the nuclear factor-κB inhibitor A20 is altered in the cystic fibrosis epithelium
Open Access
- 27 September 2012
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 41 (6) , 1315-1323
Abstract
A20 is a lipopolysaccharide (LPS)-inducible, cytoplasmic zinc finger protein, which inhibits Toll-like receptor-activated nuclear factor (NF)-κB signalling by deubiquitinating tumour necrosis factor receptor-associated factor (TRAF)-6. The action of A20 is facilitated by complex formation with ring finger protein (RNF)-11, Itch and TAX-1 binding protein-1 (TAX1BP1). This study investigated whether the expression of A20 is altered in the chronically inflamed cystic fibrosis (CF) airway epithelium.Nasal epithelial cells from CF patients (F508del homozygous), non-CF controls and immortalised epithelial cells (16HBE14o- and CFBE41o-) were stimulated with LPS. Cytoplasmic expression of A20 and expression of NF-κB subunits were analysed. Formation of the A20 ubiquitin editing complex was also investigated.In CFBE41o-, peak LPS-induced A20 expression was delayed compared with 16HBE14o- and fell significantly below basal levels 12–24 h after LPS stimulation. This was confirmed in primary CF airway cells. Additionally, a significant inverse relationship between A20 and p65 expression was observed. Inhibitor studies showed that A20 does not undergo proteasomal degradation in CFBE41o-. A20 interacted with TAX1BP1, RNF11 and TRAF6 in 16HBE14o- cells, but these interactions were not observed in CFBE41o-.The expression of A20 is significantly altered in CF, and important interactions with complex members and target proteins are lost, which may contribute to the state of chronic NF-κB-driven inflammation.Keywords
This publication has 33 references indexed in Scilit:
- Role of the A20-TRAF6 Axis in Lipopolysaccharide-mediated OsteoclastogenesisJournal of Biological Chemistry, 2011
- Deubiquitinases in the regulation of NF-κB signalingCell Research, 2010
- TAX1BP1 and A20 Inhibit Antiviral Signaling by Targeting TBK1-IKKi KinasesJournal of Biological Chemistry, 2010
- Ca2+ influx via TRPC channels induces NF-κB-dependent A20 expression to prevent thrombin-induced apoptosis in endothelial cellsAmerican Journal of Physiology-Cell Physiology, 2010
- Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme ComplexesScience, 2010
- The ubiquitin‐editing enzyme A20 requires RNF11 to downregulate NF‐κB signallingThe EMBO Journal, 2009
- Molecular Basis for the Unique Deubiquitinating Activity of the NF-κB Inhibitor A20Journal of Molecular Biology, 2008
- Essential role for TAX1BP1 in the termination of TNF‐α‐, IL‐1‐ and LPS‐mediated NF‐κB and JNK signalingThe EMBO Journal, 2007
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signallingNature, 2004